SU-Holdings Co.,Ltd. (031860.KQ)

1,486.00 +46.00 (+3.19%) At close: 03:30PM KST

SU-Holdings Co.,Ltd.

KJ Tower
8th Floor 207 Bongeunsa-ro Nonhyeon-dong, Gangnam-gu
Seoul
South Korea
82 2 2106 5417
https://su-holdings.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Moon-Wui Chung	Chief Executive Officer and President	N/A	N/A	1971

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in KRW.

Description

SU-Holdings Co.,Ltd., a medical company, develops and sells brain disease treatment devices based on image guided low intensity focused ultrasound technology in the brain neuromodulation market. Its product is NEUROSONA, a treatment device for brain disease. The company was formerly known as NSN Co., Ltd. and changed its name to SU-Holdings Co.,Ltd. in July 2023. SU-Holdings Co.,Ltd. was founded in 1979 and is based in Seoul, South Korea.

Corporate governance

SU-Holdings Co.,Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.